1. 4147The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE-/- mice by blocking proinflammatory signaling in macrophages. (28th August 2018) Authors: Kahles, F; Liberman, A; Halim, C; Mertens, R W; Rau, M; Moellmann, J; Rueckbeil, M; Walla, B; Diepolder, I; Diebold, S; Burgmaier, M; Lebherz, C; Marx, N; Lehrke, M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GLP-1 is an independent predictor of long-term mortality in patients with myocardial infarction complicated by cardiogenic shock – a substudy of the IABP-SHOCK II trial. (25th November 2020) Authors: Fuernau, G; Lehrke, M; Jung, C; Kahles, F; Lebherz, C; Eitel, I; Thelemann, N; Desch, S; Werdan, K; Zeymer, U; Adams, V; Marx, N; Thiele, H Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis. (3rd October 2022) Authors: Kahles, F; Mertens, R; Diebold, S; Arrivas, M C; Moellmann, J; Steitz, J; Mirzaei, Y; Sandoval, D; Martin, L; Schuerholz, T; Koch, A; Tacke, F; Drucker, D J; Marx, N; Lehrke, M Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The gut hormone GIP predicts CV prognosis in patients with acute myocardial infarction. (14th October 2021) Authors: Kahles, F; Rueckbeil, M V; Arrivas, M C; Mertens, R W; Moellmann, J; Biener, M; Giannitsis, E; Katus, H A; Marx, N; Lehrke, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction. (25th November 2020) Authors: Kahles, F; Mertens, R.W; Rueckbeil, M.V; Arrivas, M.C; Moellmann, J; Lebherz, C; Biener, M; Giannitsis, E; Katus, H.A; Marx, N; Lehrke, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗